RDVI ETF Analysis: FT Cboe Vest Rising | BATS

Derivative Income | BATS, USA | Market Cap: 3.526m USD | 12M Return: 27.2% | Charts, Fundamentals & Technical Analysis

Dividend Stocks, Covered Calls, Equity Options, Income Derivatives
Total Rating 70
Safety 62
Buy Signal 0.11
Derivative Income
Category Rotation: -1.5
TER: 0.75%
AUM: 3.53B
Avg Turnover: 21.5M
Risk 3d forecast
Volatility13.0%
VaR 5th Pctl2.31%
VaR vs Median-1.50%
Reward TTM
Sharpe Ratio1.49
Rel. Str. IBD64.2
Rel. Str. Peer Group91.3
Character TTM
Beta0.866
Beta Downside0.895
Hurst Exponent0.508
Drawdowns 3y
Max DD18.35%
CAGR/Max DD1.01
CAGR/Mean DD6.70

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 3.7 years of data

Jan +1.9% 38
Feb -1.7% 15
Mar -4.0% 15
Apr -2.7% 14
May +0.4% 11
Jun +3.8% 18
Jul +2.9% 29
Aug +0.9% 0
Sep -0.1% 0
Oct -1.5% 38
Nov +6.6% 39
Dec +0.0% 11

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: RDVI FT Cboe Vest Rising

RDVI is a derivative income ETF that invests at least 80% of its net assets in dividend-paying securities, with the adviser seeking to enhance distributions by combining stock dividends with premiums from options strategies (typically a covered call overlay) on the underlying holdings.

The fund targets an annual distribution rate of approximately 8.0% above the current dividend yield of the S&P 500 Index. It is classified as a non-diversified fund, launched in October 2022, and is structured as a U.S.-listed mid-cap ETF on the Cboe BATS exchange, focusing on rising dividend achievers within the equity income space.

Headlines to Watch Out For
  • Option premium income declines as market volatility falls
  • Rising interest rates pressure dividend stock valuations relative to bonds
  • Competition intensifies from JEPI and JEPQ covered call ETFs
What is the price of RDVI shares?

As of July 28, 2026, the stock is trading at USD 29.03 with a total of 777,307 shares traded. Over the past week, the price has changed by +1.02%, over one month by +0.09%, over three months by +7.38% and over the past year by +27.21%.

Current recommended Stop Loss: 28.60 (which is 1.5% or 1.3 ATR below the current price).

Is RDVI a buy, sell or hold?

FT Cboe Vest Rising has no consensus analysts rating.